MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.

Evans BC, Hocking KM, Osgood MJ, Voskresensky I, Dmowska J, Kilchrist KV, Brophy CM, Duvall CL
Sci Transl Med. 2015 7 (291): 291ra95

PMID: 26062847 · PMCID: PMC5371354 · DOI:10.1126/scitranslmed.aaa4549

Autologous vein grafts are commonly used for coronary and peripheral artery bypass but have a high incidence of intimal hyperplasia (IH) and failure. We present a nanopolyplex (NP) approach that efficiently delivers a mitogen-activated protein kinase (MAPK)-activated protein (MAPKAP) kinase 2 inhibitory peptide (MK2i) to graft tissue to improve long-term patency by inhibiting pathways that initiate IH. In vitro testing in human vascular smooth muscle cells revealed that formulation into MK2i-NPs increased cell internalization, endosomal escape, and intracellular half-life of MK2i. This efficient delivery mechanism enabled MK2i-NPs to sustain potent inhibition of inflammatory cytokine production and migration in vascular cells. In intact human saphenous vein, MK2i-NPs blocked inflammatory and migratory signaling, as confirmed by reduced phosphorylation of the posttranscriptional gene regulator heterogeneous nuclear ribonucleoprotein A0, the transcription factor cAMP (adenosine 3',5'-monophosphate) element-binding protein, and the chaperone heat shock protein 27. The molecular effects of MK2i-NPs caused functional inhibition of IH in human saphenous vein cultured ex vivo. In a rabbit vein transplant model, a 30-min intraoperative graft treatment with MK2i-NPs significantly reduced in vivo IH 28 days posttransplant compared with untreated or free MK2i-treated grafts. The decrease in IH in MK2i-NP-treated grafts in the rabbit model also corresponded with decreased cellular proliferation and maintenance of the vascular wall smooth muscle cells in a more contractile phenotype. These data indicate that nanoformulated MK2 inhibitors are a promising strategy for preventing graft failure.

Copyright © 2015, American Association for the Advancement of Science.

MeSH Terms (20)

Animals Endocytosis Endosomes Humans Hyperplasia Intracellular Signaling Peptides and Proteins Lysosomes Male Myocytes, Smooth Muscle Nanoparticles Peptides Phenotype Phosphorylation Protein-Serine-Threonine Kinases Protein Kinase Inhibitors Rabbits Saphenous Vein Treatment Outcome Tunica Intima Vascular Grafting

Connections (1)

This publication is referenced by other Labnodes entities: